Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Číst více

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Číst více

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Číst více

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Číst více

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Číst více

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Číst více

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Číst více

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Číst více

IMD Complications & Family Burden: Understanding the Multi-dimensional Impact

Explore the comprehensive impact of Invasive Meningococcal Disease (IMD), including family burden, survivor complications, and quality of life effects. Learn about neurological and non-neurological complications affecting IMD survivors.

Číst více

From Non-Specific Symptoms to a 24-Hour Crisis: How Can We Outpace the Rapid Progression of IMD?

Learn about the rapid progression of Invasive Meningococcal Disease (IMD), its clinical manifestations, and why early diagnosis is crucial for patient survival.

Číst více

Avances y nuevas fronteras en el abordaje de la diabetes tipo 1

Revisión de los desarrollos más recientes en diabetes tipo 1, incluyendo el concepto de estadios tempranos de la enfermedad, terapias dirigidas a la preservación de células beta, optimización tecnológica con sistemas automatizados y perspectivas emergentes en prevención e inmunomodulación.

Číst více

LixiLan-G Çalışması: GLP-1 RA Tedavisiyle Yetersiz Kontrol Sağlanan T2DM Hastalarında iGlarLixi’ye Geçişin Etkililiği ve Güvenliliği

Číst více